Novel genetic mutation in the background of Carney complex
Csaba Halászlaki1, István Takács, Henriett Butz
11st Department of Medicine, Semmelweis University, Korányi Sándor u. 2/A, Budapest 1083, Hungary. drhalaszlaki@gmail.com
Abstract:
Carney complex is a rare disease inherited in an autosomal dominant manner. It is mostly caused by inactivating mutations of the subunit of protein kinase A. Carney complex is associated with atrial myxoma, nevi or myxomas of the skin, breast tumor and endocrine overactivity. Primary pigmented nodular adrenocortical disease is the specific endocrine manifestation. The authors present the history of a 53-year-old female patient who had undergone surgery for atrial myxomas, thyroid tumor and breast cancer. She was also operated for an adrenal adenoma causing Cushing’s syndrome. Genetic study revealed a novel mutation in the regulatory subunit of protein kinase A (ivs2-1G>A splice mutation in intron 2). Her heterozygous twins were also genetically screened and one of them carried the same mutation. The authors emphasize that despite the absence of specific treatment for patients with Carney complex, confirmation of the diagnosis by genetic studies is important for the close follow-up of the patient and early identification of novel manifestations.
Insights
Carney complex, a rare genetic disorder, is often caused by protein kinase A mutations. Genetic testing is crucial for diagnosing this condition and monitoring patients for new symptoms.
Area of Science:
- Genetics
- Endocrinology
- Oncology
Background:
- Carney complex is a rare autosomal dominant disorder.
- It is primarily caused by inactivating mutations in the regulatory subunit of protein kinase A.
- Associated conditions include atrial myxomas, skin lesions, breast tumors, and endocrine overactivity, notably primary pigmented nodular adrenocortical disease.
Observation:
- A 53-year-old female patient with a history of atrial myxomas, thyroid tumor, breast cancer, and Cushing’s syndrome due to adrenal adenoma was studied.
- Genetic analysis identified a novel splice mutation (ivs2-1G>A) in intron 2 of the regulatory subunit of protein kinase A.
- Her heterozygous twins were screened, and one carried the identical mutation.
Findings:
- A novel inactivating mutation in the regulatory subunit of protein kinase A was identified in a patient with Carney complex.
- This mutation was also found in one of the patient's heterozygous twins.
- Primary pigmented nodular adrenocortical disease was noted as a specific endocrine manifestation.
Implications:
- Genetic confirmation of Carney complex is vital for patient management.
- Early diagnosis facilitates close monitoring and identification of potential new manifestations.
- While no specific treatment exists, genetic screening aids in proactive healthcare for affected individuals and families.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Mutagenicity and Carcinogenicity
Mutations
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...


